Constellation Pharmaceuticals, Inc.
EZH2 INHIBITOR-INDUCED GENE EXPRESSION

Abstract:

Provided herein are methods of treating subjects characterized as having a gene signature that is indicative of EZH2-inhibitor response, methods for determining said gene signature, and methods of determining which subjects may be responsive to cancer treatments based on said gene signature.